{"organizations": [], "uuid": "f9de57978202d82c415f00c0c4f8adecf1bc8b3c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/us", "section_title": "US Stock Market News - Dow Jones, Nasdaq, S&amp;P 500 | Reuters.com", "url": "https://www.reuters.com/article/brief-spring-bank-pharmaceuticals-says-n/brief-spring-bank-pharmaceuticals-says-net-loss-for-three-months-ended-march-31-2018-was-4-9-mln-or-0-37-per-share-idUSFWN1S41BT", "country": "US", "domain_rank": 408, "title": "BRIEF-Spring Bank Pharmaceuticals Says Net Loss For Three Months Ended March 31, 2018 Was $4.9 Mln, Or $0.37 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.011, "site_type": "news", "published": "2018-04-27T21:12:00.000+03:00", "replies_count": 0, "uuid": "f9de57978202d82c415f00c0c4f8adecf1bc8b3c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-spring-bank-pharmaceuticals-says-n/brief-spring-bank-pharmaceuticals-says-net-loss-for-three-months-ended-march-31-2018-was-4-9-mln-or-0-37-per-share-idUSFWN1S41BT", "ord_in_thread": 0, "title": "BRIEF-Spring Bank Pharmaceuticals Says Net Loss For Three Months Ended March 31, 2018 Was $4.9 Mln, Or $0.37 Per Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-spring bank pharmaceuticals", "sentiment": "negative"}, {"name": "spring bank pharmaceuticals inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 27, 2018 / 1:12 PM / Updated 9 minutes ago BRIEF-Spring Bank Pharmaceuticals Says Net Loss For Three Months Ended March 31, 2018 Was $4.9 Mln, Or $0.37 Per Share Reuters Staff 1 Min Read\n Spring Bank Pharmaceuticals Inc :\n* SPRING BANK PHARMACEUTICALS INC - NET LOSS FOR THREE MONTHS ENDED MARCH 31, 2018 WAS $4.9 MILLION, OR $0.37 PER SHARE\n* SPRING BANK PHARMACEUTICALS - ANTICIPATES THAT EXISTING CASH, CASH EQUIVALENTS WILL ENABLE CO TO FUND OPERATING EXPENSES & CAPEX REQUIREMENTS INTO Q4 2019\n* SPRING BANK PHARMA - ANTICIPATES THAT EXISTING CASH, CASH EQUIVALENTS WILL NOT BE SUFFICIENT TO FUND INITIATION OF ANY PHASE 3 TRIAL FOR INARIGIVIR Source text for Eikon: ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-27T21:12:00.000+03:00", "crawled": "2018-04-27T16:30:33.003+03:00", "highlightTitle": ""}